S100A16 drives hepatocellular carcinoma by promoting KCNJ8-mediated choline metabolic dysregulation and immunosuppression
Cell Death & Disease - S100A16 drives hepatocellular carcinoma by promoting KCNJ8-mediated choline metabolic dysregulation and immunosuppression